Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 4726 AL 4740

The safety and effectiveness of mirabegron in Parkinson's disease patients with overactive bladder: a randomized controlled trial

Moussa M, Chakra MA, Dabboucy B, Fares Y, Dellis A, Papatsoris A.

Scand J Urol. 2022 Feb;56(1):66-72. doi: 10.1080/21681805.2021.1990994. Epub 2021 Oct 21.

Chemically induced models of Parkinson's disease

Thirugnanam T, Santhakumar K.

Comp Biochem Physiol C Toxicol Pharmacol. 2022 Feb;252:109213. doi: 10.1016/j.cbpc.2021.109213. Epub 2021 Oct 18.

Parkinsonism and cerebrospinal fluid disorders

Youn J, Todisco M, Zappia M, Pacchetti C, Fasano A.

J Neurol Sci. 2022 Feb 15;433:120019. doi: 10.1016/j.jns.2021.120019. Epub 2021 Oct 1.

NOTCH2NLC-related disorders: the widening spectrum and genotype-phenotype correlation

Fan Y, Xu Y, Shi C.

J Med Genet. 2022 Jan;59(1):1-9. doi: 10.1136/jmedgenet-2021-107883. Epub 2021 Oct 21.

Parkinsonism and cerebrovascular disease

Narasimhan M, Schwartz R, Halliday G.

J Neurol Sci. 2022 Feb 15;433:120011. doi: 10.1016/j.jns.2021.120011. Epub 2021 Oct 6.

Adenosine receptor antagonists: Recent advances and therapeutic perspective

Saini A, Patel R, Gaba S, Singh G, Gupta GD, Monga V.

Eur J Med Chem. 2022 Jan 5;227:113907. doi: 10.1016/j.ejmech.2021.113907. Epub 2021 Oct 13.

The effect of exercise on balance in patients with stroke, Parkinson, and multiple sclerosis: a systematic review and meta-analysis of clinical trials

Salari N, Hayati A, Kazeminia M, Rahmani A, Mohammadi M, Fatahian R, Shohaimi S.

Neurol Sci. 2022 Jan;43(1):167-185. doi: 10.1007/s10072-021-05689-y. Epub 2021 Oct 28.

THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial

Corvol JC, Azulay JP, Bosse B, Dauvilliers Y, Defebvre L, Klostermann F, Kovacs N, Maltête D, Ondo WG, Pahwa R, Rein W, Thobois S, Valis M, Videnovic A, Rascol O; THN102-202 Study Investigators.

Mov Disord. 2022 Feb;37(2):410-415. doi: 10.1002/mds.28840. Epub 2021 Oct 28.

Virtual reality balance training to improve balance and mobility in Parkinson's disease: a systematic review and meta-analysis

Sarasso E, Gardoni A, Tettamanti A, Agosta F, Filippi M, Corbetta D.

J Neurol. 2022 Apr;269(4):1873-1888. doi: 10.1007/s00415-021-10857-3. Epub 2021 Oct 28.

Outcomes of hip arthroplasty in Parkinson's disease: a meta-analysis and systematic review

Zhang Y, Chu SS, Liu K, Huang Q, Wang Y.

Int Orthop. 2022 Apr;46(4):705-716. doi: 10.1007/s00264-021-05228-6. Epub 2021 Oct 28.

PTEN-induced kinase 1 (PINK1) and Parkin: Unlocking a mitochondrial quality control pathway linked to Parkinson's disease

Agarwal S, Muqit MMK.

Curr Opin Neurobiol. 2022 Feb;72:111-119. doi: 10.1016/j.conb.2021.09.005. Epub 2021 Oct 27.

Biomechanical aspects that precede freezing episode during gait in individuals with Parkinson's disease: A systematic review

Cupertino L, Dos Reis TG, Los Angeles E, Costa TM, Shokur S, Bouri M, de Lima-Pardini AC, Coelho DB.

Gait Posture. 2022 Jan;91:149-154. doi: 10.1016/j.gaitpost.2021.10.021. Epub 2021 Oct 25.

The Phenotypes and Mechanisms of NOTCH2NLC-Related GGC Repeat Expansion Disorders: a Comprehensive Review

Huang XR, Tang BS, Jin P, Guo JF.

Mol Neurobiol. 2022 Jan;59(1):523-534. doi: 10.1007/s12035-021-02616-2. Epub 2021 Oct 31.

Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment

Pathak N, Vimal SK, Tandon I, Agrawal L, Hongyi C, Bhattacharyya S.

Metab Brain Dis. 2022 Jan;37(1):67-104. doi: 10.1007/s11011-021-00800-w. Epub 2021 Nov 1.

Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of Rasagiline

Arpin DJ, Mitchell T, Archer DB, Burciu RG, Chu WT, Gao H, Guttuso T, Hess CW, Lai S, Malaty IA, McFarland NR, Pasternak O, Price CC, Shukla AW, Wu SS, Okun MS, Vaillancourt DE.

Mov Disord. 2022 Feb;37(2):325-333. doi: 10.1002/mds.28838. Epub 2021 Nov 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias